Predicting the risk of venous thromboembolism recurrence (Q26865059)

main subject

venous thromboembolism

1 reference

John A. Heit

1

1 reference

language of work or name

1 reference

May 2012

1 reference

American Journal of Hematology

published in

1 reference

volume

87 Suppl 1

1 reference

page(s)

S63-7

1 reference

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Risk assessment for recurrent venous thrombosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Venous thromboembolism: risk factors for recurrence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

The epidemiology of venous thromboembolism in the community

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Risks of oral anticoagulant therapy with increasing age.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Thrombophilia, clinical factors, and recurrent venous thrombotic events

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Major bleeding after hospitalization for deep-venous thrombosis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Recurrence of venous thromboembolism in patients with familial thrombophilia

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California.

31 May 2018

1 reference

Venous thromboembolism hospitalizations among American Indians and Alaska Natives

21 January 2018

1 reference

High plasma levels of factor VIII and risk of recurrence of venous thromboembolism

21 January 2018

1 reference

Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.

21 January 2018

1 reference

Age at first venous thromboembolism and risk of recurrence: a prospective cohort study.

21 January 2018

1 reference

The risk of recurrent venous thromboembolism in men and women

21 January 2018

1 reference

Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism

21 January 2018

1 reference

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

21 January 2018

1 reference

Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients

21 January 2018

1 reference

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators

21 January 2018

1 reference

Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.

21 January 2018

1 reference

Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.

21 January 2018

1 reference

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

21 January 2018

1 reference

Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

21 January 2018

1 reference

The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis

21 January 2018

1 reference

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

21 January 2018

1 reference

Individualized duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model.

21 January 2018

1 reference

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis

21 January 2018

1 reference

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs

21 January 2018

1 reference

Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.

21 January 2018

1 reference

Major bleeding complications in a specialized anticoagulation service

21 January 2018

1 reference

Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal

21 January 2018

1 reference

Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study

21 January 2018

1 reference

D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383031

The risk of recurrent venous thromboembolism among patients with high factor IX levels

28 November 2018

1 reference

12 December 2020

Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study

1 reference

12 December 2020

D-dimer levels and risk of recurrent venous thromboembolism

1 reference

12 December 2020

Racial and gender differences in the incidence of recurrent venous thromboembolism

1 reference

12 December 2020

Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial

1 reference

12 December 2020

High-density lipoprotein and the risk of recurrent venous thromboembolism

1 reference

12 December 2020

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study

1 reference

12 December 2020

Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism

1 reference

12 December 2020

Overweight, obesity, and the risk of recurrent venous thromboembolism

1 reference

12 December 2020

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

1 reference

12 December 2020

Deep venous thrombosis: rate of spontaneous lysis and thrombus extension

1 reference

12 December 2020

Change in thrombus length on venous ultrasound and recurrent deep vein thrombosis

1 reference

12 December 2020

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

12 December 2020

Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, Minnesota

1 reference

12 December 2020

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

12 December 2020

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

1 reference

12 December 2020

Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism

1 reference

12 December 2020

Recurrent venous thromboembolism in men and women

1 reference

12 December 2020

High risk of recurrent venous thromboembolism in men

1 reference

12 December 2020

Recurrence rate after a first venous thrombosis in patients with familial thrombophilia

1 reference

12 December 2020

Family history for venous thromboembolism and the risk for recurrence

1 reference

12 December 2020

Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time

1 reference

12 December 2020

Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism

1 reference

12 December 2020

Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors

1 reference

12 December 2020

Recurrent venous thrombosis and markers of inflammation

1 reference

12 December 2020

High plasma levels of factor VIII and the risk of recurrent venous thromboembolism

1 reference

12 December 2020

Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy

1 reference

12 December 2020

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis

1 reference

12 December 2020

Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism

1 reference

12 December 2020

Identifiers

0 references

1 reference

PubMed publication ID

22367958

1 reference